<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0041">
 <mixed-citation publication-type="other">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Tallei</surname>
    <given-names>T.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Tumilaar</surname>
    <given-names>S.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Niode</surname>
    <given-names>N.</given-names>
   </name>, Fatimawali, 
   <name name-style="western">
    <surname>Kepel</surname>
    <given-names>B.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Idroes</surname>
    <given-names>R.</given-names>
   </name> &amp; 
   <name name-style="western">
    <surname>Effendi</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: A molecular docking study</article-title>. Preprints, no. 1â€“18. 
  <pub-id pub-id-type="doi">10.20944/preprints202004.0102.v1</pub-id>.
 </mixed-citation>
</ref>
